Dynamic China Moves Into The Fast Lane Of Medtech Regulatory Improvements

 
• By Ashley Yeo

The Chinese medtech regulatory system was a key theme at the MedTech Summit in June, where regional specialists gave updates on registration timelines and electronic submissions, and signaled how the world’s biggest market-in-waiting is speeding up its regulatory improvements in a bid to become more open and less forbidding for overseas entrants.

Shanghai

China is a main draw at the Informa Connect (formerly Knect 365) MedTech Summit, held in June each year, and the 2019 event, in Brussels, Belgium, was no exception. The regulatory environment in China is “always very dynamic,” said Asia Regulatory Professional Association (ARPA) secretary Jack Wong, opening the first day of the summit’s emerging markets track.

He recalled that a few weeks prior to the summit that the Chinese regulatory agency, the National Medical Products Administration...

More from Asia

More from Geography